This project investigates four hypotheses concerning the specificity of tyrosine kinases. Constitutive or inappropriate activation of tyrosine kinases plays a role in the progression and development of various forms of human cancer. The proposed research focuses on the insulin-like growth factor I receptor (IGF1R) and Jak2 tyrosine kinases, two enzymes that have been implicated in malignant transformation. The overall hypothesis for this work is that tyrosine kinase specificity is regulated at two levels: (1) by the spatial/temporal organization of the kinase signaling pathway; and (2) by the specificity intrinsic to the kinase catalytic domain.
Aims 1 and 2 compare the signaling properties of the IGF1R and insulin receptor (IR) tyrosine kinases. The first hypothesis is that the differences in specificity between these two closely related receptors can be explained by differences in the structural and enzymatic properties of the catalytic domain.
Aims 1 and 2 compare the signaling properties of the IGF1R and insulin receptor (IR) tyrosine kinases. The first hypothesis is that the differences in specificity between these two closely related receptors can be explained by differences in the structural and enzymatic properties of the catalytic domains. The proposed experiments will test this hypothesis by analyzing IGF1R autophosphorylation, activation, and substrate specificity between these two closely related receptors can be explained by differences in the structural and enzymatic properties of the catalytic domains. The proposed experiments will test this hypothesis by analyzing IGF1R autophosphorylation, activation, and substrate specificity. The second hypothesis to be investigated is that differential phosphorylation of IRS-1 and other cellular proteins is involved in specific signaling by IR and IGF1R.
Aims 3 and 4 investigate signal transduction by the Jak2 non-receptor tyrosine kinase. The propose studies will test the hypothesis that this enzyme is regulated by autoinhibition and by intermolecular autophosphorylation. Additional experiments will address the importance of a specific interaction between Jak2 and the serine/threonine phosphatase PP2A during cytokine signalling. The goal of these studies is to provide new information on the molecular basis of substrate specificity for IGF1R and Jak2. A systematic understanding of tyrosine kinase substrate specificity is important both for identifying physiological effectors, and for designing strategies to interrupt specific signalling pathways.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA028146-22
Application #
6605476
Study Section
Subcommittee E - Prevention &Control (NCI)
Project Start
2002-07-01
Project End
2003-06-30
Budget Start
Budget End
Support Year
22
Fiscal Year
2002
Total Cost
Indirect Cost
Name
State University New York Stony Brook
Department
Type
DUNS #
804878247
City
Stony Brook
State
NY
Country
United States
Zip Code
11794
Feres, Kimberly J; Hayman, Michael J (2010) RON-expressing MCF-10A breast epithelial cells exhibit alterations of hyaluronan expression, promoting RON-mediated early adhesion events. Biochem Biophys Res Commun 391:1604-9
Feres, K J; Ischenko, I; Hayman, M J (2009) The RON receptor tyrosine kinase promotes MSP-independent cell spreading and survival in breast epithelial cells. Oncogene 28:279-88
Yondola, Mark A; Hearing, Patrick (2007) The adenovirus E4 ORF3 protein binds and reorganizes the TRIM family member transcriptional intermediary factor 1 alpha. J Virol 81:4264-71
Ullman, Amanda J; Reich, Nancy C; Hearing, Patrick (2007) Adenovirus E4 ORF3 protein inhibits the interferon-mediated antiviral response. J Virol 81:4744-52
Zhao, Chen; Du, Guangwei; Skowronek, Karl et al. (2007) Phospholipase D2-generated phosphatidic acid couples EGFR stimulation to Ras activation by Sos. Nat Cell Biol 9:706-12
Kim, Hong Joo; Taylor, Laura J; Bar-Sagi, Dafna (2007) Spatial regulation of EGFR signaling by Sprouty2. Curr Biol 17:455-61
Yoo, Jae Cheal; Hayman, Michael J (2007) Annexin II binds to SHP2 and this interaction is regulated by HSP70 levels. Biochem Biophys Res Commun 356:906-11
Tartaglia, Marco; Pennacchio, Len A; Zhao, Chen et al. (2007) Gain-of-function SOS1 mutations cause a distinctive form of Noonan syndrome. Nat Genet 39:75-9
Reich, Nancy C (2007) STAT dynamics. Cytokine Growth Factor Rev 18:511-8
Merritt, Rebecca; Hayman, Michael J; Agazie, Yehenew M (2006) Mutation of Thr466 in SHP2 abolishes its phosphatase activity, but provides a new substrate-trapping mutant. Biochim Biophys Acta 1763:45-56

Showing the most recent 10 out of 281 publications